Since the Anti-Monopoly Law came into effect in 2008, China has established a merger control regime now administered by the State Administration for Market Regulation (SAMR). Transactions that meet the notification...more
7/25/2025
/ Administrative Agencies ,
Antitrust Provisions ,
China ,
Competition ,
Corporate Sales Transactions ,
Enforcement Actions ,
Judicial Review ,
Merger Agreements ,
Merger Controls ,
Pharmaceutical Industry ,
Regulatory Requirements ,
State Administration for Market Regulation (SAMR) ,
Threshold Requirements
This monthly report outlines key developments in China’s antitrust sector for July. SAMR Solicits Public Comments on the Revised Provisions on the Prohibition of Monopoly Agreements, Refining the “Safe Harbor” Standards for...more
7/21/2025
/ Administrative Agencies ,
Antitrust Provisions ,
China ,
Competition ,
Compliance ,
Enforcement Actions ,
Merger Controls ,
Mergers ,
Monopolization ,
New Legislation ,
Popular ,
Regulatory Reform ,
Regulatory Requirements ,
Safe Harbors ,
State Administration for Market Regulation (SAMR) ,
Unfair Competition
This monthly report outlines key developments in China’s antitrust sector for May. The following events merit special attention...more
5/28/2025
/ Abuse of Power ,
Acquisition Agreements ,
Anti-Competitive ,
Anti-Monopoly ,
Antitrust Investigations ,
Antitrust Provisions ,
Antitrust Violations ,
China ,
Competition ,
DuPont ,
Enforcement Actions ,
Merger Agreements ,
Merger Controls ,
Monopolization ,
Popular ,
State Administration for Market Regulation (SAMR)
This monthly report outlines key developments in China’s antitrust sector for April. The following events merit special attention...more
4/17/2025
/ Abuse of Dominance ,
Acquisition Agreements ,
Antitrust Provisions ,
China ,
Competition ,
Corporate Sales Transactions ,
Enforcement Actions ,
Government Agencies ,
Hong Kong ,
Merger Agreements ,
Merger Controls ,
Monopolization ,
New Guidance ,
Penalties ,
Pharmaceutical Industry ,
State Administration for Market Regulation (SAMR)
On March 4, 2025, CK Hutchison Holdings Limited (“CK Hutchison”), controlled by the Li Ka-Shing family, announced a significant transaction on the Hong Kong Stock Exchange: the proposed sale of 80% equity in its port business...more
3/24/2025
/ Antitrust Provisions ,
BlackRock ,
CFIUS ,
China ,
Competition ,
Foreign Investment ,
Hong Kong ,
International Trade ,
Merger Controls ,
Mergers ,
National Security